Received Apr 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
Sharing Paxlovid; Sharing Paxlovid; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown), as dose 5 (booster), single (Batch/Lot number: unknown), as dose 6 (booster), single (Batch/Lot number: unknown) and as dose 7 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Sharing Paxlovid". Therapeutic measures were taken as a result of drug ineffective, covid-19 included PAXLOVID. Clinical course: The patient's husband reported that "All 7 of our injections have been Pfizer products. we didn't get the very last updated, maybe that's why we got nailed this time it was pretty bad.".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500043426 same reporter/product/event, different patients;